SynthesisJournal of medicine and life2025
Controversies in the management of arthrocentesis treatment of temporomandibular joint disorders: systematic review.
Synthesis in Journal of medicine and life, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There is a paucity of evidence regarding whether the effective outcomes of arthrocentesis in the management of temporomandibular joint disorders (TMJD) result from its use as a single treatment or in association with adjunctive therapy. The study aimed to compare arthrocentesis alone (ACA) and arthrocentesis (AC) associated with adjunctive therapy (AAAT) to determine the most effective treatment strategy. A systematic review was conducted in September 2023 using PubMed/MEDLINE, Scopus, Web of Science, and the Cochrane Oral Health database. Outcomes assessed included pain, maximal interincisal opening (MIO)/maximum mouth opening (MMO), and joint sounds. A total of 28 studies comprising 1,216 patients treated with ACA or AAAT were included. Across these studies, 31 temporomandibular disorder diagnoses were reported, with temporomandibular joint osteoarthritis (TMJ-OA) being the most common (32.3%), followed by temporomandibular joint internal derangement (TMJ-ID) (19.4%) and disc displacement without reduction (DDwoR) (12.9%). Comparisons showed no significant differences between ACA and arthrocentesis combined with hyaluronic acid (AC + HA) or corticosteroids (AC + CS) in most studies. Arthrocentesis combined with platelet-rich plasma (AC + PRP) was superior to ACA but generally less effective than arthrocentesis combined with PRP and HA (AC + PRP + HA). The benefit of adjunctive therapy after AC remains controversial; however, an additional effect of two different adjunctive modalities after AC seems evident.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.